Coherus Pfcf Ratio from 2010 to 2024

CHRS Stock  USD 1.26  0.02  1.56%   
Coherus BioSciences PFCF Ratio yearly trend continues to be comparatively stable with very little volatility. PFCF Ratio is likely to outpace its year average in 2024. From the period from 2010 to 2024, Coherus BioSciences PFCF Ratio quarterly data regression had r-value of  0.13 and coefficient of variation of  3,487. View All Fundamentals
 
PFCF Ratio  
First Reported
2010-12-31
Previous Quarter
(1.79)
Current Value
(1.70)
Quarterly Volatility
24.44954166
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Coherus BioSciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Coherus BioSciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2 M, Interest Expense of 42.6 M or Selling General Administrative of 100.1 M, as well as many indicators such as Price To Sales Ratio of 1.16, Dividend Yield of 0.0 or Days Sales Outstanding of 388. Coherus financial statements analysis is a perfect complement when working with Coherus BioSciences Valuation or Volatility modules.
  
Check out the analysis of Coherus BioSciences Correlation against competitors.
For more information on how to buy Coherus Stock please use our How to Invest in Coherus BioSciences guide.

Latest Coherus BioSciences' Pfcf Ratio Growth Pattern

Below is the plot of the Pfcf Ratio of Coherus BioSciences over the last few years. It is Coherus BioSciences' PFCF Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Coherus BioSciences' overall financial position and show how it may be relating to other accounts over time.
Pfcf Ratio10 Years Trend
Pretty Stable
   Pfcf Ratio   
       Timeline  

Coherus Pfcf Ratio Regression Statistics

Arithmetic Mean0.70
Geometric Mean7.04
Coefficient Of Variation3,487
Mean Deviation13.69
Median(3.68)
Standard Deviation24.45
Sample Variance597.78
Range112
R-Value0.13
Mean Square Error632.44
R-Squared0.02
Significance0.64
Slope0.73
Total Sum of Squares8,369

Coherus Pfcf Ratio History

2024 -1.7
2023 -1.79
2022 -2.53
2021 -31.1
2020 8.44
2019 81.16
2018 -3.68

About Coherus BioSciences Financial Statements

Coherus BioSciences shareholders use historical fundamental indicators, such as Pfcf Ratio, to determine how well the company is positioned to perform in the future. Although Coherus BioSciences investors may analyze each financial statement separately, they are all interrelated. The changes in Coherus BioSciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Coherus BioSciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
PFCF Ratio(1.79)(1.70)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Coherus Stock Analysis

When running Coherus BioSciences' price analysis, check to measure Coherus BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coherus BioSciences is operating at the current time. Most of Coherus BioSciences' value examination focuses on studying past and present price action to predict the probability of Coherus BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coherus BioSciences' price. Additionally, you may evaluate how the addition of Coherus BioSciences to your portfolios can decrease your overall portfolio volatility.